Login to Your Account



Alkermes, Cephalon: FDA Calls Vivitrol Approvable

By Randall Osborne


Friday, December 30, 2005
Pending final work on labeling and delivery of some preclinical pharmacokinetic data to the FDA, Alkermes Inc. and Cephalon Inc. have won marketing clearance for Vivitrol (formerly Vivitrex), their injectable drug against alcohol dependence. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription